233 related articles for article (PubMed ID: 23735743)
1. HIV/AIDS eradication.
Marsden MD; Zack JA
Bioorg Med Chem Lett; 2013 Jul; 23(14):4003-10. PubMed ID: 23735743
[TBL] [Abstract][Full Text] [Related]
2. Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus.
Chun TW; Justement JS; Moir S; Hallahan CW; Maenza J; Mullins JI; Collier AC; Corey L; Fauci AS
J Infect Dis; 2007 Jun; 195(12):1762-4. PubMed ID: 17492591
[TBL] [Abstract][Full Text] [Related]
3. Latently infected cell activation: a way to reduce the size of the HIV reservoir?
Forde J; Volpe JM; Ciupe SM
Bull Math Biol; 2012 Jul; 74(7):1651-72. PubMed ID: 22562387
[TBL] [Abstract][Full Text] [Related]
4. Viral sanctuaries during highly active antiretroviral therapy in a nonhuman primate model for AIDS.
North TW; Higgins J; Deere JD; Hayes TL; Villalobos A; Adamson L; Shacklett BL; Schinazi RF; Luciw PA
J Virol; 2010 Mar; 84(6):2913-22. PubMed ID: 20032180
[TBL] [Abstract][Full Text] [Related]
5. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
Pierson T; McArthur J; Siliciano RF
Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
[TBL] [Abstract][Full Text] [Related]
6. HIV eradication revisited.
Vella S; Palmisano L
Expert Opin Investig Drugs; 2000 Feb; 9(2):193-7. PubMed ID: 11060670
[TBL] [Abstract][Full Text] [Related]
7. Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs.
Katlama C; Deeks SG; Autran B; Martinez-Picado J; van Lunzen J; Rouzioux C; Miller M; Vella S; Schmitz JE; Ahlers J; Richman DD; Sekaly RP
Lancet; 2013 Jun; 381(9883):2109-17. PubMed ID: 23541541
[TBL] [Abstract][Full Text] [Related]
8. The challenge of finding a cure for HIV infection.
Richman DD; Margolis DM; Delaney M; Greene WC; Hazuda D; Pomerantz RJ
Science; 2009 Mar; 323(5919):1304-7. PubMed ID: 19265012
[TBL] [Abstract][Full Text] [Related]
9. HIV latency in the humanized BLT mouse.
Marsden MD; Kovochich M; Suree N; Shimizu S; Mehta R; Cortado R; Bristol G; An DS; Zack JA
J Virol; 2012 Jan; 86(1):339-47. PubMed ID: 22072769
[TBL] [Abstract][Full Text] [Related]
10. Exosomal Tat protein activates latent HIV-1 in primary, resting CD4+ T lymphocytes.
Tang X; Lu H; Dooner M; Chapman S; Quesenberry PJ; Ramratnam B
JCI Insight; 2018 Apr; 3(7):. PubMed ID: 29618654
[TBL] [Abstract][Full Text] [Related]
11. Can HIV infection be eradicated through use of potent antiviral agents?
Josefsson L; Dahl V; Palmer S
Curr Opin Infect Dis; 2010 Dec; 23(6):628-32. PubMed ID: 20847693
[TBL] [Abstract][Full Text] [Related]
12. Latent reservoirs of HIV: obstacles to the eradication of virus.
Chun TW; Fauci AS
Proc Natl Acad Sci U S A; 1999 Sep; 96(20):10958-61. PubMed ID: 10500107
[TBL] [Abstract][Full Text] [Related]
13. In vivo analysis of the effect of panobinostat on cell-associated HIV RNA and DNA levels and latent HIV infection.
Tsai P; Wu G; Baker CE; Thayer WO; Spagnuolo RA; Sanchez R; Barrett S; Howell B; Margolis D; Hazuda DJ; Archin NM; Garcia JV
Retrovirology; 2016 May; 13(1):36. PubMed ID: 27206407
[TBL] [Abstract][Full Text] [Related]
14. Chimeric Antigen Receptor T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate Virus Reactivated from Latency in CD4+ T Lymphocytes Isolated from HIV-1-Infected Individuals Receiving Suppressive Combined Antiretroviral Therapy.
Liu B; Zou F; Lu L; Chen C; He D; Zhang X; Tang X; Liu C; Li L; Zhang H
J Virol; 2016 Nov; 90(21):9712-9724. PubMed ID: 27535056
[TBL] [Abstract][Full Text] [Related]
15. Maraviroc Is Associated with Latent HIV-1 Reactivation through NF-κB Activation in Resting CD4
Madrid-Elena N; García-Bermejo ML; Serrano-Villar S; Díaz-de Santiago A; Sastre B; Gutiérrez C; Dronda F; Coronel Díaz M; Domínguez E; López-Huertas MR; Hernández-Novoa B; Moreno S
J Virol; 2018 May; 92(9):. PubMed ID: 29444937
[TBL] [Abstract][Full Text] [Related]
16. Finding a cure for HIV: will it ever be achievable?
Lewin SR; Evans VA; Elliott JH; Spire B; Chomont N
J Int AIDS Soc; 2011 Jan; 14():4. PubMed ID: 21255462
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Approaches to Eradicate Latent HIV-1 in Resting CD4+ T Cells.
Sluis-Cremer N
Curr Top Med Chem; 2016; 16(10):1191-7. PubMed ID: 26324046
[TBL] [Abstract][Full Text] [Related]
18. Barriers to HIV Cure.
Stein J; Storcksdieck Genannt Bonsmann M; Streeck H
HLA; 2016 Oct; 88(4):155-63. PubMed ID: 27620852
[TBL] [Abstract][Full Text] [Related]
19. Can the viral reservoir of latently infected CD4(+) T cells be eradicated with antiretroviral HIV drugs?
Smith RJ; Aggarwala BD
J Math Biol; 2009 Nov; 59(5):697-715. PubMed ID: 19165438
[TBL] [Abstract][Full Text] [Related]
20. Nonnucleoside Reverse Transcriptase Inhibitors Reduce HIV-1 Production from Latently Infected Resting CD4
Zerbato JM; Tachedjian G; Sluis-Cremer N
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
